Global Action featured a new trial for an aHUS treatment iptacopan earlier this year ( CLICK ON IMAGE BELOW)
aHUS Trial Watch 15 (Iptacopan)
Iptacopan is a complement inhibitor that it is taken orally, twice daily. It works by inhibiting Complement Factor B (CFB ). Without CFB , C5 cannot be activated to create the membrane attack complex C5b-9. CONTINUE READING first article for more information.
At that time only three investigation sites were recruiting. That number has been increased with sites in seven other counties including the USA ( Los Angeles and Albuqueque) . Also sites in Brazil, South Korea and Taiwan and most noticeably India.
See all the current recruiting sites listed below.
Iptacopan is an oral medicine taken twice a day to inhibit Complement.
United States, California | |
Novartis Investigative Site | Recruiting |
Torrance, California, United States, 90502 | |
United States, New Mexico | |
Novartis Investigative Site | Recruiting |
Albuquerque, New Mexico, United States, 87131 | |
Austria | |
Novartis Investigative Site | Recruiting |
Innsbruck, Tyrol, Austria, 6020 | |
Novartis Investigative Site | Recruiting |
Wien, Austria, 1090 | |
Brazil | |
Novartis Investigative Site | Recruiting |
Sao Paulo, SP, Brazil, 05403 000 | |
Novartis Investigative Site | Recruiting |
São Paulo, SP, Brazil, 04038-002 | |
Czechia | |
Novartis Investigative Site | Recruiting |
Praha 4, Czechia, 140 00 | |
Praha, Czechia, 12808 | |
Ostrava Poruba, Czech Republic, Czechia, 708 52 | |
Greece | |
Novartis Investigative Site | Recruiting |
Thessaloniki, GR, Greece, 570 10 | |
India | |
Novartis Investigative Site | Recruiting |
Vellore, Tamil Nadu, India, 632004 | |
Lucknow, Uttar Pradesh, India, 226014 | |
Japan | |
Novartis Investigative Site | Recruiting |
Iruma-gun, Saitama, Japan, 350-0495 | |
Novartis Investigative Site | Recruiting |
Izumo-city, Shimane, Japan, 693 8501 | |
Korea, Republic of | |
Novartis Investigative Site | Recruiting |
Seoul, Korea, Republic of, 03080 | |
Novartis Investigative Site | Recruiting |
Seoul, Korea, Republic of, 03722 | |
Slovenia | |
Novartis Investigative Site | Recruiting |
Ljubljana, Slovenia, 1000 | |
Taiwan | |
Novartis Investigative Site | Recruiting |
Taichung, Taiwan, 40447 | |
Novartis Investigative Site | Recruiting |
Taoyuan, Taiwan, 33305 | |
United Kingdom Novartis Investigative Site Recruiting | |
Newcastle Upon Tyne, United Kingdom, NE7 7DN |
Article No. 524